149 related articles for article (PubMed ID: 35561523)
41. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
zur Hausen H
J Natl Cancer Inst; 2000 May; 92(9):690-8. PubMed ID: 10793105
[TBL] [Abstract][Full Text] [Related]
42. Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review.
Sannigrahi MK; Sharma R; Panda NK; Khullar M
Oral Dis; 2018 Nov; 24(8):1417-1427. PubMed ID: 28941018
[TBL] [Abstract][Full Text] [Related]
43. Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.
Pešut E; Đukić A; Lulić L; Skelin J; Šimić I; Milutin Gašperov N; Tomaić V; Sabol I; Grce M
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835040
[TBL] [Abstract][Full Text] [Related]
44. miRNA as viral transcription tuners in HPV-mediated cervical carcinogenesis.
Shishodia G; Verma G; Das BC; Bharti AC
Front Biosci (Schol Ed); 2018 Jan; 10(1):21-47. PubMed ID: 28930517
[TBL] [Abstract][Full Text] [Related]
45. Detection of HPV E6/E7 mRNA in Clinical Samples Using RNA In Situ Hybridization.
Pandey M; Bhosale PG; Mahimkar MB
Methods Mol Biol; 2018; 1726():167-175. PubMed ID: 29468552
[TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
47. The interplay between non-coding RNAs and Twist1 signaling contribute to human disorders.
Ghafouri-Fard S; Abak A; Bahroudi Z; Shoorei H; Abbas Raza SH; Taheri M
Biomed Pharmacother; 2021 Mar; 135():111220. PubMed ID: 33433357
[TBL] [Abstract][Full Text] [Related]
48. MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.
Luna AJ; Sterk RT; Griego-Fisher AM; Chung JY; Berggren KL; Bondu V; Barraza-Flores P; Cowan AT; Gan GN; Yilmaz E; Cho H; Kim JH; Hewitt SM; Bauman JE; Ozbun MA
PLoS Pathog; 2021 Jan; 17(1):e1009216. PubMed ID: 33481911
[TBL] [Abstract][Full Text] [Related]
49. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
Mittal S; Banks L
Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
[TBL] [Abstract][Full Text] [Related]
50. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
[TBL] [Abstract][Full Text] [Related]
51. 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
Morel A; Baguet A; Perrard J; Demeret C; Jacquin E; Guenat D; Mougin C; Prétet JL
Oncotarget; 2017 Jul; 8(28):46163-46176. PubMed ID: 28521287
[TBL] [Abstract][Full Text] [Related]
52. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
53. The Deubiquitinase USP46 Is Essential for Proliferation and Tumor Growth of HPV-Transformed Cancers.
Kiran S; Dar A; Singh SK; Lee KY; Dutta A
Mol Cell; 2018 Dec; 72(5):823-835.e5. PubMed ID: 30415951
[TBL] [Abstract][Full Text] [Related]
54. MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.
Pedroza-Torres A; López-Urrutia E; García-Castillo V; Jacobo-Herrera N; Herrera LA; Peralta-Zaragoza O; López-Camarillo C; De Leon DC; Fernández-Retana J; Cerna-Cortés JF; Pérez-Plasencia C
Molecules; 2014 May; 19(5):6263-81. PubMed ID: 24840898
[TBL] [Abstract][Full Text] [Related]
55. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
[TBL] [Abstract][Full Text] [Related]
56. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
57. MiR-875 and miR-3144 switch the human papillomavirus 16 E6/E6* mRNA ratio through the EGFR pathway and a direct targeting effect.
Li Y; Cai Q; Lin L; Xu C
Gene; 2018 Dec; 679():389-397. PubMed ID: 30205176
[TBL] [Abstract][Full Text] [Related]
58. Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification.
Hong S; Cheng S; Songock W; Bodily J; Laimins LA
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978708
[TBL] [Abstract][Full Text] [Related]
59. Human papillomaviruses and associated malignancies.
Alani RM; Münger K
J Clin Oncol; 1998 Jan; 16(1):330-7. PubMed ID: 9440761
[TBL] [Abstract][Full Text] [Related]
60. Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature.
Giuliani L; Favalli C; Syrjanen K; Ciotti M
Anticancer Res; 2007; 27(4C):2697-704. PubMed ID: 17695435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
